Molecular Diagnostics Market Size, Share, Trends, Growth Outlook

Molecular Diagnostics Market is estimated to increase at a growth rate of 11.1% CAGR over the forecast period from 2024 to 2032.

 

The Molecular Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Instruments, Reagents, Others), By Technology (Polymerase chain reaction (PCR), In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others, By Application (Oncology, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, Others), By Test (Point of Care, Self-test or OTC, Central Laboratories).

 

An Introduction to Molecular Diagnostics Market in 2024

The Molecular Diagnostics Market is poised for substantial growth in 2024, driven by the increasing prevalence of infectious diseases, cancer, genetic disorders, and chronic conditions, coupled with advancements in genomics, proteomics, and molecular biology technologies. Molecular diagnostics involve the detection and analysis of nucleic acids, proteins, and other biomolecules to diagnose diseases, predict treatment response, monitor therapeutic efficacy, and guide personalized medicine approaches.

Key drivers of the molecular diagnostics market include the growing demand for rapid, accurate, and sensitive diagnostic tests, the rising adoption of point-of-care testing (POCT) and molecular assays in clinical laboratories and decentralized settings, and the expanding applications of molecular techniques in infectious disease screening, oncology, pharmacogenomics, and prenatal testing. Additionally, technological innovations in nucleic acid amplification, next-generation sequencing (NGS), digital PCR, microarrays, and bioinformatics drive the development of advanced molecular diagnostic platforms, multiplex assays, and companion diagnostics, enabling the detection of multiple targets with high specificity and sensitivity.

Furthermore, the integration of molecular diagnostics into routine clinical practice, disease surveillance programs, and public health initiatives enhances disease prevention, early detection, and management strategies, contributing to improved patient outcomes and healthcare delivery. Moreover, strategic collaborations between diagnostic companies, academic research institutions, and healthcare organizations accelerate innovation and product development in the molecular diagnostics field, fostering the commercialization of novel assays, biomarkers, and diagnostic technologies tailored to specific diseases and patient populations. Regulatory approvals, reimbursement policies, and quality assurance standards governing molecular diagnostic tests and laboratory practices also play a crucial role in market expansion and adoption, ensuring test accuracy, reliability, and patient safety.

Molecular Diagnostics Market Trend: Adoption of Next-Generation Sequencing (NGS) Technologies

A prominent trend in the molecular diagnostics market is the adoption of Next-Generation Sequencing (NGS) technologies. NGS platforms enable high-throughput sequencing of nucleic acids, offering unprecedented insights into genetic variations, disease mechanisms, and personalized treatment approaches. As the cost of sequencing continues to decline and the throughput and accuracy of NGS platforms improve, there is increasing adoption of NGS-based molecular diagnostic tests for applications such as cancer genomics, infectious disease profiling, and pharmacogenomics. This trend reflects a shift towards comprehensive genomic profiling and personalized medicine, driving market growth in the molecular diagnostics segment.

Molecular Diagnostics Market Driver: Growing Demand for Precision Medicine and Targeted Therapies

A significant driver in the molecular diagnostics market is the growing demand for precision medicine and targeted therapies. Precision medicine aims to tailor medical treatments to individual patient characteristics, including genetic makeup, molecular biomarkers, and disease profiles. Molecular diagnostic tests play a critical role in identifying biomarkers, detecting genetic mutations, and predicting treatment responses, enabling clinicians to make informed decisions about therapy selection, dosage optimization, and patient management. With increasing recognition of the importance of personalized treatment approaches in improving patient outcomes and reducing healthcare costs, there is escalating demand for molecular diagnostic assays that support precision medicine initiatives, driving market growth in the molecular diagnostics segment.

Molecular Diagnostics Market Opportunity: Development of Liquid Biopsy Assays for Non-Invasive Disease Monitoring

An exciting potential opportunity in the molecular diagnostics market lies in the development of liquid biopsy assays for non-invasive disease monitoring. Liquid biopsies involve the analysis of circulating biomarkers, such as cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), and extracellular vesicles, in bodily fluids such as blood, urine, and saliva. These assays offer a minimally invasive and real-time approach to disease monitoring, enabling early detection of cancer recurrence, treatment response assessment, and minimal residual disease detection. By investing in research and development efforts focused on liquid biopsy technologies, molecular diagnostics companies can introduce innovative assays that improve patient outcomes, enable dynamic disease monitoring, and drive market growth in the molecular diagnostics segment.

 

Molecular Diagnostics Market Segmentation

By Product

• Instruments
• Reagents
• Others

By Technology

• Polymerase chain reaction (PCR)
• In Situ Hybridization (ISH)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Chips and Microarrays
• Mass Spectrometry
• Sequencing
• Transcription Mediated Amplification (TMA)
• Others 

By Application

• Oncology

     -Breast Cancer
     -Prostate Cancer
     -Colorectal Cancer
     -Cervical Cancer
     -Other Cancers

• Pharmacogenomics
• Infectious Diseases

     -Methicillin-resistant Staphylococcus Aureus (MRSA)
     -Clostridium Difficile
     -Vancomycin-resistant Enterococci (VRE)
     -Carbapenem-resistant Bacteria
     -Flu
     -Respiratory Syncytial Virus (RSV)
     -Candida
     -Other Infectious Diseases

• Genetic Testing

     -Newborn Screening
     -Predictive and Presymptomatic Testing
     -Other Genetic Testing

• Neurological Disease
• Cardiovascular Disease
• Microbiology
• Others

By Test 

• Point of Care
• Self-test or OTC
• Central Laboratories

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

Molecular Diagnostics Market Companies

• Abbott
• Agilent Technologies, Inc.
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Danaher
• F. Hoffmann-La Roche, Ltd.
• Grifols, S.A.
• Hologic Inc. (Gen Probe)
• Illumina, Inc.
• QIAGEN
• Siemens Healthineers AG
• Sysmex Corporation

 

*List not exhaustive

 

Reasons to Buy the Molecular Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Molecular Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Molecular Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

Molecular Diagnostics Market Outlook 2024

1 Market Overview

1.1 Introduction to the Molecular Diagnostics Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2024 Molecular Diagnostics Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Molecular Diagnostics Market Companies with Area Served

4.2.2 Products Offerings Global Molecular Diagnostics Market

 

5 Recession Impact Analysis and Outlook Scenarios

5.1.1 Recission Impact Analysis

5.1.2 Market Growth Scenario- Base Case

5.1.3 Market Growth Scenario- Reference Case

5.1.4 Market Growth Scenario- High Case

 

6 Global Molecular Diagnostics Market Trends

6.1 Global Molecular Diagnostics Revenue (USD Million) and CAGR (%) by Type (2018-2032)

6.2 Global Molecular Diagnostics Revenue (USD Million) and CAGR (%) by Applications (2018-2032)

6.3 Global Molecular Diagnostics Revenue (USD Million) and CAGR (%) by regions (2018-2032)

 

7 Global Molecular Diagnostics Market Revenue (USD Million) by Type, and Applications (2018-2023)

7.1 Global Molecular Diagnostics Revenue (USD Million) by Type (2018-2023)

7.1.1 Global Molecular Diagnostics Revenue (USD Million), Market Share (%) by Type (2018-2023)

7.2 Global Molecular Diagnostics Revenue (USD Million) by Applications (2018-2023)

7.2.1 Global Molecular Diagnostics Revenue (USD Million), Market Share (%) by Applications (2018-2023)

 

8 Global Molecular Diagnostics Development Regional Status and Outlook

8.1 Global Molecular Diagnostics Revenue (USD Million) By Regions (2018-2023)

8.2 North America Molecular Diagnostics Revenue (USD Million) by Type, and Application (2018-2023)

8.2.1 North America Molecular Diagnostics Revenue (USD Million) by Country (2018-2023)

8.2.2 North America Molecular Diagnostics Revenue (USD Million) by Type (2018-2023)

8.2.3 North America Molecular Diagnostics Revenue (USD Million) by Applications (2018-2023)

8.3 Europe Molecular Diagnostics Revenue (USD Million), by Type, and Applications (USD Million) (2018-2023)

8.3.1 Europe Molecular Diagnostics Revenue (USD Million), by Country (2018-2023)

8.3.2 Europe Molecular Diagnostics Revenue (USD Million) by Type (2018-2023)

8.3.3 Europe Molecular Diagnostics Revenue (USD Million) by Applications (2018-2023)

8.4 Asia Pacific Molecular Diagnostics Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2023)

8.4.1 Asia Pacific Molecular Diagnostics Revenue (USD Million) by Country (2018-2023)

8.4.2 Asia Pacific Molecular Diagnostics Revenue (USD Million) by Type (2018-2023)

8.4.3 Asia Pacific Molecular Diagnostics Revenue (USD Million) by Applications (2018-2023)

8.5 South America Molecular Diagnostics Revenue (USD Million), by Type, and Applications (2018-2023)

8.5.1 South America Molecular Diagnostics Revenue (USD Million), by Country (2018-2023)

8.5.2 South America Molecular Diagnostics Revenue (USD Million) by Type (2018-2023)

8.5.3 South America Molecular Diagnostics Revenue (USD Million) by Applications (2018-2023)

8.6 Middle East and Africa Molecular Diagnostics Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2023)

8.6.1 Middle East and Africa Molecular Diagnostics Revenue (USD Million) by Country (2018-2023)

8.6.2 Middle East and Africa Molecular Diagnostics Revenue (USD Million) by Type (2018-2023)

8.6.3 Middle East and Africa Molecular Diagnostics Revenue (USD Million) by Applications (2018-2023)

 

9 Company Profiles

 

10 Global Molecular Diagnostics Market Revenue (USD Million), by Type, and Applications (2024-2032)

10.1 Global Molecular Diagnostics Revenue (USD Million) and Market Share (%) by Type (2024-2032)

10.1.1 Global Molecular Diagnostics Revenue (USD Million), and Market Share (%) by Type (2024-2032)

10.2 Global Molecular Diagnostics Revenue (USD Million) and Market Share (%) by Applications (2024-2032)

10.2.1 Global Molecular Diagnostics Revenue (USD Million), and Market Share (%) by Applications (2024-2032)

 

11 Global Molecular Diagnostics Development Regional Status and Outlook Forecast

11.1 Global Molecular Diagnostics Revenue (USD Million) By Regions (2024-2032)

11.2 North America Molecular Diagnostics Revenue (USD Million) by Type, and Applications (2024-2032)

11.2.1 North America Molecular Diagnostics Revenue (USD) Million by Country (2024-2032)

11.2.2 North America Molecular Diagnostics Revenue (USD Million), by Type (2024-2032)

11.2.3 North America Molecular Diagnostics Revenue (USD Million), Market Share (%) by Applications (2024-2032)

11.3 Europe Molecular Diagnostics Revenue (USD Million), by Type, and Applications (2024-2032)

11.3.1 Europe Molecular Diagnostics Revenue (USD Million), by Country (2024-2032)

11.3.2 Europe Molecular Diagnostics Revenue (USD Million), by Type (2024-2032)

11.3.3 Europe Molecular Diagnostics Revenue (USD Million), by Applications (2024-2032)

11.4 Asia Pacific Molecular Diagnostics Revenue (USD Million) by Type, and Applications (2024-2032)

11.4.1 Asia Pacific Molecular Diagnostics Revenue (USD Million), by Country (2024-2032)

11.4.2 Asia Pacific Molecular Diagnostics Revenue (USD Million), by Type (2024-2032)

11.4.3 Asia Pacific Molecular Diagnostics Revenue (USD Million), by Applications (2024-2032)

11.5 South America Molecular Diagnostics Revenue (USD Million), by Type, and Applications (2024-2032)

11.5.1 South America Molecular Diagnostics Revenue (USD Million), by Country (2024-2032)

11.5.2 South America Molecular Diagnostics Revenue (USD Million), by Type (2024-2032)

11.5.3 South America Molecular Diagnostics Revenue (USD Million), by Applications (2024-2032)

11.6 Middle East and Africa Molecular Diagnostics Revenue (USD Million), by Type, and Applications (2024-2032)

11.6.1 Middle East and Africa Molecular Diagnostics Revenue (USD Million), by region (2024-2032)

11.6.2 Middle East and Africa Molecular Diagnostics Revenue (USD Million), by Type (2024-2032)

11.6.3 Middle East and Africa Molecular Diagnostics Revenue (USD Million), by Applications (2024-2032)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Molecular Diagnostics Market Companies with Areas Served

Table 3 Products Offerings Global Molecular Diagnostics Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Molecular Diagnostics Revenue (USD Million) And CAGR (%) By Type (2018-2032)

Table 8 Global Molecular Diagnostics Revenue (USD Million) And CAGR (%) By Applications (2018-2032)

Table 9 Global Molecular Diagnostics Revenue (USD Million) And CAGR (%) By Regions (2018-2032)

Table 10 Global Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Table 11 Global Molecular Diagnostics Revenue Market Share (%) By Type (2018-2023)

Table 12 Global Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Table 13 Global Molecular Diagnostics Revenue Market Share (%) By Applications (2018-2023)

Table 14 Global Molecular Diagnostics Market Revenue (USD Million) By Regions (2018-2023)

Table 15 Global Molecular Diagnostics Market Share (%) By Regions (2018-2023)

Table 16 North America Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Table 17 North America Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Table 18 North America Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Table 19 Europe Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Table 20 Europe Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Table 21 Europe Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Table 22 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Table 23 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Table 24 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Table 25 South America Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Table 26 South America Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Table 27 South America Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Table 28 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Region (2018-2023)

Table 29 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Table 30 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Table 31 Financial Analysis

Table 32 Global Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Table 33 Global Molecular Diagnostics Revenue Market Share (%) By Type (2024-2032)

Table 34 Global Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Table 35 Global Molecular Diagnostics Revenue Market Share (%) By Applications (2024-2032)

Table 36 Global Molecular Diagnostics Market Revenue (USD Million), And Revenue (USD Million) By Regions (2024-2032)

Table 37 North America Molecular Diagnostics Revenue (USD)By Country (2024-2032)

Table 38 North America Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Table 39 North America Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Table 40 Europe Molecular Diagnostics Revenue (USD Million) By Country (2024-2032)

Table 41 Europe Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Table 42 Europe Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Table 43 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Country (2024-2032)

Table 44 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Table 45 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Table 46 South America Molecular Diagnostics Revenue (USD Million) By Country (2024-2032)

Table 47 South America Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Table 48 South America Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Table 49 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Region (2024-2032)

Table 50 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Region (2024-2032)

Table 51 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Table 52 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Figure 4 Global Molecular Diagnostics Revenue Market Share (%) By Type (2023)

Figure 5 Global Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Figure 6 Global Molecular Diagnostics Revenue Market Share (%) By Applications (2023)

Figure 7 Global Molecular Diagnostics Market Revenue (USD Million) By Regions (2018-2023)

Figure 8 Global Molecular Diagnostics Market Share (%) By Regions (2023)

Figure 9 North America Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Figure 10 North America Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Figure 11 North America Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Figure 12 Europe Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Figure 13 Europe Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Figure 14 Europe Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Figure 15 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Figure 16 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Figure 17 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Figure 18 South America Molecular Diagnostics Revenue (USD Million) By Country (2018-2023)

Figure 19 South America Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Figure 20 South America Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Figure 21 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Region (2018-2023)

Figure 22 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Type (2018-2023)

Figure 23 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Applications (2018-2023)

Figure 24 Global Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Figure 25 Global Molecular Diagnostics Revenue Market Share (%) By Type (2030)

Figure 26 Global Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Figure 27 Global Molecular Diagnostics Revenue Market Share (%) By Applications (2030)

Figure 28 Global Molecular Diagnostics Market Revenue (USD Million) By Regions (2024-2032)

Figure 29 North America Molecular Diagnostics Revenue (USD Million) By Country (2024-2032)

Figure 30 North America Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Figure 31 North America Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Figure 32 Europe Molecular Diagnostics Revenue (USD Million) By Country (2024-2032)

Figure 33 Europe Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Figure 34 Europe Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Figure 35 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Country (2024-2032)

Figure 36 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Figure 37 Asia Pacific Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Figure 38 South America Molecular Diagnostics Revenue (USD Million) By Country (2024-2032)

Figure 39 South America Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Figure 40 South America Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Figure 41 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Region (2024-2032)

Figure 42 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Region (2024-2032)

Figure 43 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Type (2024-2032)

Figure 44 Middle East and Africa Molecular Diagnostics Revenue (USD Million) By Applications (2024-2032)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

Molecular Diagnostics Market Segmentation

By Product

• Instruments
• Reagents
• Others

By Technology

• Polymerase chain reaction (PCR)
• In Situ Hybridization (ISH)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Chips and Microarrays
• Mass Spectrometry
• Sequencing
• Transcription Mediated Amplification (TMA)
• Others 

By Application

• Oncology

     -Breast Cancer
     -Prostate Cancer
     -Colorectal Cancer
     -Cervical Cancer
     -Other Cancers

• Pharmacogenomics
• Infectious Diseases

     -Methicillin-resistant Staphylococcus Aureus (MRSA)
     -Clostridium Difficile
     -Vancomycin-resistant Enterococci (VRE)
     -Carbapenem-resistant Bacteria
     -Flu
     -Respiratory Syncytial Virus (RSV)
     -Candida
     -Other Infectious Diseases

• Genetic Testing

     -Newborn Screening
     -Predictive and Presymptomatic Testing
     -Other Genetic Testing

• Neurological Disease
• Cardiovascular Disease
• Microbiology
• Others

By Test 

• Point of Care
• Self-test or OTC
• Central Laboratories

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)